22

2020

-

04

How to promote the resumption of production in the pharmaceutical industry.


Drugs are an important material basis and condition guarantee for epidemic prevention and control, and are used in the first line of medical treatment to save people and reduce the stock of patients. The material security team has always taken medical security and drug security as the top priority, strengthened the production monitoring of key drugs, comprehensively promoted the resumption of production in the pharmaceutical industry, strengthened the coordination of the production and supply of raw materials, urged enterprises to expand production and transformation, and made every effort to ensure the production and supply of key drugs. Mainly three aspects of work:

One is to carry out prevention and control drug production monitoring. The first time to establish a national key medical materials security scheduling platform, drugs and other key medical materials production resumption of work to track and monitor the situation. At present, the capacity recovery rate of monitoring products has reached the normal level, and most of the products are in sufficient supply.

The second is to organize the production of key drugs. Closely follow the progress of the new crown pneumonia drug research and development, in the relevant drugs into the "diagnosis and treatment program", to ensure a stable and sufficient supply to achieve "drugs and others". Coordination of chloroquine phosphate, abidor and fapiravir in the "diagnosis and treatment plan" was intensified, and production was fully resumed in early February.

Three is to strengthen the clinical treatment of traditional Chinese medicine production scheduling. The 14 kinds of Chinese patent medicines included in the "Diagnosis and Treatment Plan" have been monitored in a timely manner, such as some key varieties such as Lianhua Qingwen and Jinhua Qingan. The company has been producing at full capacity, with relatively sufficient inventory and guaranteed market supply.

In the next step, we will continue to strengthen production scheduling, coordinate and solve the practical difficulties encountered in the production of enterprises, and make every effort to ensure the production and supply of key drugs.Should.